A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults
Authors:
- P Van DammePDP Van Damme
- E JoossensEJE Joossens
- G FrançoisGFG François
- F MeuriceFMF Meurice
- A RamalhoARA Ramalho
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Adult Pertussis: A Salesman's Dream—and an Epidemiologist's NightmareBiologicals, 1997
- Future Combined VaccinesThe Journal of Infectious Diseases, 1996
- Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infantsThe Journal of Pediatrics, 1996
- Acellular Pertussis VaccinesDrug Safety, 1996
- Does Tetanus Immune Globulin Interfere with the Immune Response to Simultaneous Administration of Tetanus-Diphtheria Vaccine? A Comparative Clinical Trial in AdultsThe Journal of Clinical Pharmacology, 1995
- Cost Benefit of Combining AntigensBiologicals, 1994
- Long-term persistence of anti-diphtheria toxin antibodies among adults in IsraelEuropean Journal of Epidemiology, 1994
- Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in childrenEuropean Journal of Pediatrics, 1993
- Seroepidemiology of Pertussis in ItalyClinical Infectious Diseases, 1991
- Acellular pertussis vaccine in adults: Adverse reactions and immune responseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987